Hi! Simply click below and type your query.
Our experts will reply you very soon.
Daclatasvir, used in combination with sofosbuvir for the treatment of patients with chronic hepatitis c virus (hcv)genotype 3 infection. Compared to other treatment options, this combination not only increases the cure rate, but is also regarded as a valuable treatment option in some of the difficult-to-treat hcv patient subsets.Natco will market generic daclatasvir under its own brand natdac, and through its strategic partners in india.